Stay updated on VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial
Sign up to get notified when there's something new on the VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial page.

Latest updates to the VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added, and the preceding funding-status notice as well as Revision: v3.4.1 were removed. These appear to be site-wide maintenance updates and do not alter the study details.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide notice about a lapse in government funding and that the NIH Clinical Center is open has been added, along with a revision update from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedShow glossary option added and study record metadata updated to revision v3.4.0. Minor capitalization and phrasing adjustments were made to QC criteria and FEAR Act data labels.SummaryDifference0.2%

- Check64 days agoChange DetectedA consolidated Locations section has been added listing Ohio, Texas, and Washington as study sites, replacing the prior state-specific location subsections, and the page revision label updated to v3.3.3; the HHS Vulnerability Disclosure link was removed.SummaryDifference0.5%

- Check85 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2. No substantive study details appear to be changed.SummaryDifference0.1%

- Check92 days agoChange DetectedPublications section now indicates entries are automatically filled from PubMed, and the page revision is updated to v3.3.1.SummaryDifference0.1%

Stay in the know with updates to VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial page.